ARTICLE SYNOPSIS...Novavax is a specialty biopharmaceutical company engaged in the research, development, and commercialization of proprietary products focused on drug delivery and biological technologies -- in this season of flu, a share to watch.
ARTICLE SYNOPSIS...This specialty biopharmaceutical company leaps out of a consolidation pattern as it eyes previous resistance levels.
ARTICLE SYNOPSIS...News that cases of human-to-human transmission of the deadly avian flu may have been discovered sent biotechnology stocks, including Novavax, higher.